Therefore, there is still considerable interest in identifying a small molecule NLRP3 inhibitor that has the potential of increasing efficacy, reducing side effects, and could be used to manage NLRP3-related neuroinflammatory and CNS disorders. This evidence concerns the gene NLRP3 and central nervous system disorder.